Anti-ALCAM/CD166 Antibody (Praluzatamab ravtansine)
Catalog No.
F1127
Anti-ALCAM/CD166 Antibody (Praluzatamab ravtansine)
Featured Products
Praluzatamab ravtansine (CX-2009) is a conditionally activated Probody drug conjugate (PDC) comprising an anti-CD166 mAb conjugated to DM4 with a protease-cleavable linker and a peptide mask that restricts target engagement to tissues and circulation under normal conditions.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
2145115-85-9
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
CX-2009, CX-191
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q13740
Human,Cynomolgus [US10745481]
DM4
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
ALCAM / CD166
Please avoid freeze-thaw cycles.